Investigating the 2-oxoglutarate oxygenase JMJD4 as a novel anti-cancer target

Project Details

Short titleInvestigating the 2-oxoglutarate oxygenase JMJD4 as a novel anti-cancer target
StatusFinished
Effective start/end date1/10/1330/09/17

Funding

  • GlaxoSmithKline